2018
DOI: 10.4244/eij-d-18-00101
|View full text |Cite
|
Sign up to set email alerts
|

Radial haemostasis is facilitated with a potassium ferrate haemostatic patch: the Statseal with TR Band assessment trial (STAT)

Abstract: The PFHP haemostatic patch facilitated early deflation of the TRB with a non-significant increase in forearm haematomas. Use of the PFHP may improve patient throughput and allow earlier discharge following transradial procedures.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
6
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 13 publications
4
6
0
Order By: Relevance
“…In our study the hemostasis time was reduced by 3 hr from 225 to 42 min ( p < .001) with a similar reduction in time to termination of radial protocol. The reduction in hemostasis time is comparable to reported results with a different hemostatic pad, StatSeal 14,15 . Reduced compression time will improve patient comfort and facilitate cath lab logistics.…”
Section: Discussionsupporting
confidence: 76%
“…In our study the hemostasis time was reduced by 3 hr from 225 to 42 min ( p < .001) with a similar reduction in time to termination of radial protocol. The reduction in hemostasis time is comparable to reported results with a different hemostatic pad, StatSeal 14,15 . Reduced compression time will improve patient comfort and facilitate cath lab logistics.…”
Section: Discussionsupporting
confidence: 76%
“…We have recently demonstrated that the use of a potassium ferrate patch facilitates early TR band deflation at 66 min, compared with 113 min with the TR band alone. Notably, despite 41% of patients receiving less than 5,000 units of UFH, RAO rates were less than 1%, similar to other studies with short compression 1,4,5 …”
supporting
confidence: 87%
“…5 The combined use of transradial band (TRB) with a haemostatic device may allow ease of use with reduced haemostasis time. 6 Patent haemostasis is also likely to be achieved with the combined use of both devices and possibly improve radial artery patency with the added benefit of reduced bleeding complications. So far two trials have been undertaken that compared RCD alone with RCD plus catechol conjugated homeostasis pads.…”
Section: Open Accessmentioning
confidence: 99%